Istvan Petak: We have officially launched BRECISE in Madrid
Istvan Petak, Founder and CEO/CSO at Genomate Health, shared a post on LinkedIn:
“It is official: BRECISE has started!
I am excited to share that we have officially launched our new Innovative Health Initiative (IHI) project in Madrid! In the next five years, Genomate Health will work with 30 fantastic partners, including industry, academia, and technology companies across Europe, to improve the precision care of prostate and bladder cancer patients. We thank the organizers, Ralf Hoffmann and Xenia Beltran Jaunsarás, for putting together this fantastic consortium and IHI for their support.
I also thank our colleague Barbara Vodicska PhD, for leading our part in this project and congratulate her on her excellent presentation of our technology to our partners.
More information is available here – europa.eu and euapm.eu.”
More posts featuring Istvan Petak
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023